Targeting fibrinolytic agents to the vessel wall: a new therapeutic niche?
More
R S
RS
Underwood
M J
MJ
De Bono
D P
DP
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000276:immunology; D004730:Endothelium, Vascular / Q000276:immunology; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D013927:Thrombosis / Q000517:prevention & control; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000493:pharmacokinetics; D014656:Vascular Surgical Procedures
D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; D014568:Urokinase-Type Plasminogen Activator